DaVita Operating Margin 2010-2024 | DVA

Current and historical operating margin for DaVita (DVA) over the last 10 years. The current operating profit margin for DaVita as of March 31, 2024 is 6.89%.
DaVita Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-03-31 $12.34B $1.78B 14.39%
2023-12-31 $12.14B $1.60B 13.20%
2023-09-30 $11.91B $1.47B 12.33%
2023-06-30 $11.74B $1.29B 10.95%
2023-03-31 $11.67B $1.31B 11.25%
2022-12-31 $11.61B $1.34B 11.53%
2022-09-30 $11.64B $1.47B 12.65%
2022-06-30 $11.63B $1.64B 14.06%
2022-03-31 $11.62B $1.69B 14.56%
2021-12-31 $11.62B $1.80B 15.47%
2021-09-30 $11.58B $1.79B 15.46%
2021-06-30 $11.57B $1.75B 15.16%
2021-03-31 $11.53B $1.67B 14.51%
2020-12-31 $11.55B $1.70B 14.68%
2020-09-30 $11.54B $1.78B 15.38%
2020-06-30 $11.52B $1.72B 14.89%
2020-03-31 $11.49B $1.77B 15.39%
2019-12-31 $11.39B $1.64B 14.43%
2019-09-30 $11.31B $1.57B 13.87%
2019-06-30 $11.25B $1.48B 13.15%
2019-03-31 $11.30B $1.46B 12.89%
2018-12-31 $11.40B $1.53B 13.38%
2018-09-30 $11.36B $1.29B 11.33%
2018-06-30 $11.28B $1.39B 12.36%
2018-03-31 $11.09B $1.35B 12.14%
2017-12-31 $10.88B $1.81B 16.66%
2017-09-30 $7.77B $2.18B 28.03%
2017-06-30 $8.74B $2.60B 29.79%
2017-03-31 $9.76B $2.54B 26.04%
2016-12-31 $10.71B $2.03B 18.96%
2016-09-30 $10.76B $1.72B 16.02%
2016-06-30 $10.56B $1.41B 13.39%
2016-03-31 $10.28B $1.57B 15.24%
2015-12-31 $9.98B $1.14B 11.39%
2015-09-30 $13.58B $1.38B 10.15%
2015-06-30 $13.30B $1.31B 9.82%
2015-03-31 $13.04B $1.31B 10.05%
2014-12-31 $12.80B $1.82B 14.19%
2014-09-30 $12.53B $1.85B 14.74%
2014-06-30 $12.28B $1.79B 14.55%
2014-03-31 $11.98B $1.82B 15.23%
2013-12-31 $11.77B $1.55B 13.17%
2013-09-30 $11.18B $1.45B 13.01%
2013-06-30 $10.13B $1.42B 14.00%
2013-03-31 $9.17B $1.14B 12.47%
2012-12-31 $8.19B $1.30B 15.84%
2012-09-30 $7.46B $1.26B 16.93%
2012-06-30 $7.27B $1.24B 17.07%
2012-03-31 $7.02B $1.24B 17.68%
2011-12-31 $6.73B $1.16B 17.16%
2011-09-30 $6.41B $1.05B 16.44%
2011-06-30 $6.30B $0.99B 15.74%
2011-03-31 $6.22B $0.99B 15.84%
2010-12-31 $6.22B $0.99B 15.98%
2010-09-30 $6.36B $0.98B 15.42%
2010-06-30 $6.28B $0.97B 15.41%
2010-03-31 $6.21B $0.96B 15.49%
2009-12-31 $6.10B $0.94B 15.41%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.274B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00